Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CTO navigation innovation

This article was originally published in The Gray Sheet

Executive Summary

Stereotaxis announces agreement Oct. 18 with Baylis Medical to develop and commercialize a magnetically steerable radio frequency (RF) guidewire to cross both coronary and peripheral chronic total occlusions. The collaboration combines Stereotaxis' Niobe magnetic navigation system and Baylis' RF energy delivery system to facilitate maneuverability through fully occluded vessels. CTO devices have battled technical and financial headwinds entering the market (1"The Gray Sheet" March 6, 2006, p. 13)...

You may also be interested in...

Firms Face Uphill Battle To Break Open Chronic Total Occlusion Market

Despite recent advances in specialized guidewires, industry has struggled to develop effective new technologies to aid in opening coronary chronic total occlusions, according to interventionalists

COVID-19 Vaccine 'Brexit Bonus' A Myth

The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.

Warning Letter Close-Outs – November 2020

The US Food and Drug Administration posted two device-related closeout letters in November.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts